Celldex Therapeutics
CLDX
CLDX
148 hedge funds and large institutions have $1.03B invested in Celldex Therapeutics in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 13 closing their positions.
Holders
148
Holders Change
+13
Holders Change %
+9.63%
% of All Funds
4.3%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
47
Reduced
43
Closed
13
Calls
$24.4M
Puts
$25.9M
Net Calls
-$1.48M
Net Calls Change
+$15.5M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Nomura Holdings
Tokyo,
Japan
| – | -$834K | -3,427 | Closed |
|
|
ACM
152
Apex Capital Management
Dayton,
Ohio
| – | -$589K | -2,405 | Closed |
|
153
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$490K | -2,000 | Closed |
|
|
PI
154
Putnam Investments
Boston,
Massachusetts
| – | -$449K | -1,836 | Closed |
|
|
CSS
155
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$247K | -1,009 | Closed |
|
|
TMC
156
Trellus Management Company
Delray Beach,
Florida
| – | -$183K | -747 | Closed |
|
|
ST
157
Spot Trading
Chicago,
Illinois
| – | -$159K | -651 | Closed |
|
|
VFA
158
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$124K | -508 | Closed |
|
|
BJ
159
BlackRock Japan
Tokyo,
Japan
| – | -$2K | -8 | Closed |
|